Organization Announcements

Organization Announcements


Paul G. Allen Frontiers Group [to 13 Mar 2021] ess/
No new digest content identified.


BARDA – U.S. Department of HHS [to 13 Mar 2021]
No new digest content identified.


BMGF – Gates Foundation [to 13 Mar 2021]
Press Releases and Statements
No new digest content identified.


Bill & Melinda Gates Medical Research Institute [to 13 Mar 2021]
The Bill & Melinda Gates Medical Research Institute is a non-profit biotech organization. Our mission is to develop products to fight malaria, tuberculosis, and diarrheal diseases—three major causes of mortality, poverty, and inequality in developing countries. The world has unprecedented scientific tools at its disposal; now is the time to use them to save the lives of the world’s poorest people
LOS ANGELES (March 8, 2021) — The Lundquist Institute (TLI) and The Bill & Melinda Gates Medical Research Institute (Gates MRI) executed a license agreement for TLI intellectual property covering a synthetic lung surfactant formulation to be developed for respiratory distress syndrome (RDS) for premature infants in Low- and Middle-Income countries (LMIC). TLI already maintains patents on this invention in the United States, Canada and Europe…


CARB-X [to 13 Mar 2021]
03.09.2021  |
CARB-X is funding Affinivax to develop a novel vaccine to prevent Staphylococcus aureus bacterial infections
CARB-X is funding Affinivax, a Cambridge, Massachusetts, USA, biotech, to develop a new vaccine that will prevent Staphylococcus aureus bacterial infections, healthcare-associated infections that are a major health threat particularly to high-risk and older patients.


Center for Vaccine Ethics and Policy – GE2P2 Global Foundation [to 13 Mar 2021]
:: Past weekly editions of Vaccines and Global Health: The Week in Review are available here.
:: A new edition of Informed Consent: A Monthly Digest is now posted here and via a PDF.


CEPI – Coalition for Epidemic Preparedness Innovations [to 13 Mar 2021]
Latest News
10 Mar 2021
Global leaders support CEPI plan to tackle risk of future pandemics
Support comes as CEPI launches case for $3.5 billion case for investment including an ‘all-in-one’ vaccine against coronaviruses, including SARS, MERS-CoV and SARS-CoV-2

CEPI and SK bioscience expand partnership to develop vaccine against COVID-19 variants
Up to $14.2 million of funding will support development of a vaccine against COVID-19 variants of concern
10 Mar 2021

CEPI and VBI Vaccines collaborate to advance vaccine candidates against COVID-19 variants
Up to $33m of funding will support development of VBI’s enveloped virus-like particle (eVLP) vaccine candidates against COVID-19 variants of concern.
10 Mar 2021



Meeting discusses COVID-19 vaccine manufacturing bottlenecks that must be urgently tackled for COVID-19 vaccine output to reach its full potential
09 Mar 2021


DARPA – Defense Advanced Research Projects Agency [to 13 Mar 2021
No new digest content identified.


Duke Global Health Innovation Center [to 13 Mar 2021]
Launch and Scale Speedometer
March 1, 2021


EDCTP [to 13 Mar 2021]
The European & Developing Countries Clinical Trials Partnership (EDCTP) aims to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related and neglected infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials
08 March 2021
International Women’s Day 2021: a challenge to inequality


Emory Vaccine Center [to 13 Mar 2021]
Vaccine Center News
No new digest content identified.


European Commission [to 13 Mar 2021]
Press release 11 March 2021
Commission extends transparency and authorisation mechanism for exports of COVID-19 vaccines
The Commission has today extended until end of June the transparency and authorisation mechanism for COVID-19 vaccine exports. This follows persistent delays in some of the deliveries of vaccines to the EU.
Executive Vice-President and Commissioner for Trade Valdis Dombrovskis said: “The first weeks of the application of this instrument have shown that the trade disruption feared by many did not take place. Since the measure was introduced, shipments were authorised to more than 30 countries. This confirms that even during a very critical health situation, the EU has made a considerable effort to be a reliable and responsible trading partner.”
Commissioner for Health and Food Safety Stella Kyriakides said: “We expect companies with which we have signed a contract to fulfil their obligations towards EU citizens. The EU exports very significant volumes of COVID-19 vaccines, true to our commitment to global solidarity. Yet, not all companies are honouring their agreements with the EU despite having received a down payment to enable sufficient production. We will insist that compliance is ensured and we will continue to work with companies to ramp up production in Europe as quickly as possible.”
EU number one supplier of COVID-19 vaccines to the world
The EU continues to be the leading provider of vaccines around the world. Six weeks into the existence of this mechanism, 249 export requests to 31 different countries* have been granted for a total of 34,090,267 doses, as they did not threaten the contractual engagements between the EU and the vaccine producers. Only one export request was not granted. The main export destinations include the United Kingdom (with approximately 9.1 million doses), Canada (3.9 million), Mexico (3.1 million), Japan (2.7 million), Saudi Arabia (1.4 million), Hong Kong (1.3 million), Singapore (1 million), United States (1 million), Chile (0.9 million) and Malaysia (0.8 million).
The export authorisation mechanism
This export authorisation mechanism only applies to exports from companies with which the EU has concluded Advance Purchase Agreements (APAs). These APAs commit the vaccine producers to deliver to EU Member States a pre-agreed number of vaccines. The mechanism provides for authorisations of exports of COVID-19 vaccines outside the EU…
[See COVID above for detail]

Press release 11 March 2021
European Commission authorises fourth safe and effective vaccine against COVID-19
Today, the European Commission has granted a conditional marketing authorisation (CMA) for the COVID19 vaccine developed by Janssen Pharmaceutica NV, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, and the fourth COVID-19 vaccine authorised in the EU.
[See COVID above for detail]

Press release 10 March 2021
Commission supports Member States in tackling coronavirus hotspots with offer of four million additional doses of BioNTech-Pfizer vaccine to be delivered this month
The European Commission has reached an agreement with BioNTech-Pfizer for the supply of four million more doses of COVID-19 vaccines for Member States in the next two weeks in order to tackle coronavirus hotspots and to facilitate free border movement.
[See COVID above for detail]


European Medicines Agency [to 13 Mar 2021]
News & Press Releases
News: COVID-19 Vaccine AstraZeneca: PRAC investigating cases of thromboembolic events – vaccine’s benefits currently still outweigh risks – Update
PRAC, Last updated: 11/03/2021



News: EMA recommends COVID-19 Vaccine Janssen for authorisation in the EU
CHMP, Last updated: 11/03/2021
[See COVID above for detail]



News: EMA starts rolling review of Eli Lilly antibodies bamlanivimab and etesevimab for COVID-19
CHMP, Last updated: 11/03/2021



News: COVID-19 Vaccine AstraZeneca: PRAC preliminary view suggests no specific issue with batch used in Austria
PRAC, Last updated: 10/03/2021
[See COVID above for detail]


European Vaccine Initiative [to 13 Mar 2021]
Latest News
Effective vaccine against placental malaria: Where we are and what does the future
Macrh 9, 2021
A new review article on Placental Malaria has been published in Frontiers in Immunology. The publication, entitled Progress and Insights Toward an Effective Placental Malaria Vaccine, results from long standing collaboration of over 15 years between European Vaccine Initiative and researchers at Inserm and University of Copenhagen…. Read the full article >>


FDA [to 13 Mar 2021]
Press Announcements /Selected Details
March 12, 2021 – Coronavirus (COVID-19) Update: March 12, 2021

March 9, 2021 – Coronavirus (COVID-19) Update: March 9, 2021


FDA – COVID-19 Vaccines [to 13 Mar 2021]
News and Updates; Upcoming Events
House Subcommittee Hearing on COVID-19 Vaccinations
FDA leadership will participate in the House Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce hearing entitled, “Leading the Way Forward: Biden Administration Actions to Increase COVID-19 Vaccinations.”


Fondation Merieux [to 13 Mar 2021]
News, Events
Mérieux Foundation co-organized event
Advanced Course on Diagnostics (ACDx): Special Edition on COVID-19
March 15 – 17, 2021 – Virtual


Gavi [to 13 Mar 2021]
News Releases
No new digest content identified.


GHIT Fund [to 13 Mar 2021]
GHIT was set up in 212 with the aim of developing new tools to tackle infectious diseases that
Press Releases
No new digest content identified.


Global Fund [to 13 Mar 2021]
News & Stories
Global Fund Thanks the United States for US$3.5 Billion Emergency Investment to Fight COVID-19
11 March 2021
The Global Fund applauds the U.S. government for approving US$3.5 billion in emergency funding for the Global Fund’s effort to fight the COVID-19 pandemic in low- and middle-income countries.

Global Fund Gets Top Marks in New Report on Gender Equality in Global Health
08 March 2021
The Global Fund to Fight AIDS, Tuberculosis and Malaria is honored to be ranked as one of the “12 very high-scoring” organizations on gender equality in the Global Health 50/50 Report, released today. The report, entitled Gender equality: Flying Blind in A Time of Crisis, surveyed 201 global health organizations to assess how gender equality is being advanced both within the organizations and in the health programs they run. The report identified 45 high scorers in 2021, including 12 very high-scoring organizations and 33 high-scoring organizations.


Global Research Collaboration for Infectious Disease Preparedness [GloPID-R] [to 13 Mar 2021]
No new digest content identified.


Hilleman Laboratories [to 13 Mar 2021]
No new digest content identified.


Human Vaccines Project [to 13 Mar 2021]
No new digest content identified.


IAVI [to 13 Mar 2021]
March 12, 2021
Innovative bio-therapeutics for COVID-19: How can monoclonal antibodies for SARS-CoV-2 be made accessible in LMICs?
On February 24, 2021, IAVI co-organized a webinar with the Department of Biotechnology (Ministry of Science and Technology, Government of India), and Wellcome to understand the challenges and opportunities for research and development of innovative biotherapeutic treatments for COVID-19, such as monoclonal antibodies (mAbs), and raise awareness about the necessity of ensuring access to these products for patients across the world. The webinar was organized as three panel discussions with an impressive and diverse group of panelists from global and regional health organizations, regulatory organizations, academic institutions, and private industry, including product developers and manufacturers.
See IAVI and Wellcome call to action, you can access the full recording of the webinar here.
A recording of the previous webinar in this series, co-convened by IAVI, Wellcome, and Unitaid, on how COVID-19 may pave the way for global access to monoclonal antibodies can be found via Wellcome. To read a summary of the convening, follow this link.



International Coalition of Medicines Regulatory Authorities [ICMRA]
Selected Statements, Press Releases, Research
No new digest content identified.



International Generic and Biosimilar Medicines Association [IGBA]
Press Releases/Announcements
No new digest content identified.



Press Releases/Announcements
No new digest content identified.


IFRC [to 13 Mar 2021]
Selected Press Releases, Announcements
COVID-19: IFRC warns of “deadly gap” in global efforts to distribute vaccines
Geneva, 10 March 2021 – Nascent efforts to ensure fair and equitable distribution of COVID-19 vaccines will fail unless a “deadly gap” in global immunization policy and funding is quickly filled. This is the stark warning issued today by the Internatio …
10 March 2021

New report: Migrants hit an “invisible wall” in accessing COVID-19 care and vaccines
Geneva, 9 March 2021 – A new report released today documents an “invisible wall” which has blocked migrants from accessing basic services since the start of the COVID-19 pandemic, and is now preventing them from accessing vaccines. The report – Locked down and left out? Why access to basic services for migrants is critical to our COVID-19 response and recovery – draws on research carried out across all regions by the newly established Red Cross Red Crescent Global Migration Lab, hosted by Australian Red Cross and supported by the International Federation of Red Cross and Red Crescent Societies (IFRC) and the International Committee of the Red Cross (ICRC).
Jagan Chapagain, IFRC Secretary General said: “Our research reveals what we are calling an ‘invisible wall’ that has blocked migrants – particularly those undocumented or in an irregular situation – from accessing basic services. Interestingly, this wall isn’t built mainly of policies designed to exclude migrants. Instead, it is made up of inadvertent exclusions, as well as the unintended consequences of efforts to contain and control the pandemic.”…


Institut Pasteur [to 13 Mar 2021]
No new digest content identified.


IRC International Rescue Committee [to 13 Mar 2021]
Media highlights [Selected]
Press Release
New IRC analysis: Excess COVID-19 vaccines secured by US, UK and EU sufficient to vaccinate 20+ countries facing worst humanitarian crises 
March 10, 2021
:: The US, UK and the EU have each pre-purchased enough approved COVID-19 doses to vaccinate their populations more than twice over. These excess doses could vaccinate people aged 16 and over of all 20 of IRC’s 2021 Emergency Watchlist countries.
:: 46 million people over the age of 60 living in these countries are at immediate risk and most have little hope for a vaccine in 2021.


IVAC [to 13 Mar 2021]
Updates; Events
Webinar: SARS-CoV-2 Variants and the Safety of COVID-19 Vaccines in the U.S.
The International Vaccine Access Center (IVAC) will host a webinar on March 23, 2021 at 11am ET, “SARS-CoV-2 Variants and the Safety of COVID-19 Vaccines in the U.S.
Register Here
Description: Join us for a special webinar presentation about COVID-19 vaccine safety in the U.S., and the potential impact new variants will have on vaccine effectiveness. The speed and coordination of the response against COVID-19 and development of vaccines is unprecedented, but there are still unknowns and issues to overcome. In a moderated conversation hear from experts on safety monitoring, reporting, and challenges with emerging variants.


IVI [to 13 Mar 2021]
Selected IVI News, Announcements, Events
IVI signs Memorandum of Understanding with the Nepal Health Research Council
March 12, 2021 – SEOUL, South Korea – The International Vaccine Institute (IVI) and the Nepal Health Research Council (NHRC) signed a Memorandum of Understanding (MoU) today during a virtual ceremony, laying the foundation for the two organizations to build research and development capacity in Nepal and jointly pursue opportunities to improve public health in the region…

IVI welcomes Bangladesh’s accession to IVI
March 9, 2021 – SEOUL, South Korea – The International Vaccine Institute (IVI) welcomes the Cabinet of Bangladesh’s decision to ratify the IVI Establishment Agreement on February 22, 2021, completing the full accession process to IVI and becoming its 19th State Party…


JEE Alliance [to 13 Mar 2021]
Selected News and Events
No new digest content identified.


Johns Hopkins Center for Health Security [to 13 Mar 2021]
Center News
Center for Health Security hosts the Seventh United States–India Strategic Dialogue on Biosecurity
March 10, 2021
The virtual session focused on COVID-19 responses in India and the United States. The session explored lessons learned thus far and the path forward for both nations in responding to the pandemic…


MSF/Médecins Sans Frontières [to 13 Mar 2021]
Latest [Selected Announcements]
Health needs grow for people in former safe haven of Marib
Project Update 11 Mar 2021

Photo Story
A year of a pandemic: our response to COVID-19 in pictures
11 Mar 2021

Coronavirus COVID-19 pandemic
One year of a pandemic
Opinion 11 Mar 2021

Access to medicines
Countries obstructing COVID-19 patent waiver must allow negotiations to start
Press Release 9 Mar 2021
:: Ahead of talks at the WTO on patents on COVID-19 tools, a small number of countries continue to block a waiver that would open up access to these tools during the pandemic.
:: Should the waiver be agreed, countries could produce COVID-19 vaccines and drugs on a larger scale, at lower prices.
:: MSF urges these countries to immediately stop blocking the proposal to allow lives to be saved.


National Vaccine Program Office – U.S. HHS [to 13 Mar 2021]
Upcoming Meetings/Latest Updates
No new digest content identified.


NIH [to 13 Mar 2021]
News Releases
Statement on NIH starting enrollment for third trial of blood clotting treatments for COVID-19
March 8, 2021 — Trial explores the use of the Eliquis® in patients who have been discharged from the hospital following a diagnosis of moderate-to-severe COVID-19.


UN OCHA Office for the Coordination of Humanitarian Affairs [to 13 Mar 2021]
Selected Research, Announcement
No new digest content identified.


Organization of American States (OAS) [to 13 Mar 2021]
Press Releases
Statement by the Secretary General of the Organization of American States on Equitable Distribution of Vaccines
March 9, 2021
The COVID-19 pandemic is the worst public health crisis the modern world has ever faced. It is deeply troubling that the member states of the Organization of American States (OAS) now account for almost half of the number of persons infected with the novel coronavirus globally, and a similar proportion of the people who have died worldwide.

The pandemic has also devastated the economies of the member states, particularly those that are highly dependent on external sources of income, such as tourism.

Unemployment has skyrocketed, poverty and inequality have increased, and investment has declined. The economic outlook is especially gloomy for Small Island Developing States which, by virtue of their size, produce a narrow range of goods and services that are also highly vulnerable to external shocks and natural disasters.

COVID-19 vaccines offer the prospect of supressing the virus and setting every nation on a path to both health and economic recovery. However, access to and distribution of the vaccines is not equal. Based on the current levels of limited vaccine availability and distribution, the pandemic will continue even longer for most of the world’s population, including those in Latin America and the Caribbean, depriving them of their right to life, health and livelihoods.

While I welcome the COVAX facility, led by the World Health Organization, which was designed to help developing countries to secure access to vaccines at affordable prices, I believe that COVAX needs more than pledges of financial support; it urgently needs delivery of the necessary funds to facilitate a fair supply and distribution of vaccines.

No country is safe until every country is safe. Therefore, I join the call for a massive scaling-up of vaccine production and for more affordable pricing to allow developing countries to secure vaccines and inoculate their people.



I also call on all States to facilitate the export, equal access, and equitable distribution of COVID-19 vaccines, in accordance with international human rights obligations and the Sustainable Development Goals of the UN 2030 Agenda.

The global pandemic requires a global response based on unity, solidarity, and multilateral cooperation, to ensure that all States have access to vaccines. The Americas, too, need a hemispheric response.

In this regard, I commit the OAS General Secretariat to work with our member states, the Pan American Health Organisation (PAHO) and international partners to formulate and implement solutions in the shortest possible time.



Increasing access to the Covid-19 vaccine in the Americas means increasing access to different rights in the Hemisphere such as the right to life, right to health, right to education, and right to sustainable livelihoods.

A hemispheric commitment is necessary to ensure the Americas actively embarks on the road towards post-Covid recovery and growth.


PATH [to 13 Mar 2021]
Press Releases
No new digest content identified.


Sabin Vaccine Institute [to 13 Mar 2021]
Statements and Press Releases
No new digest content identified.


UNAIDS [to 13 Mar 2021]
Selected Press Releases/Reports/Statements
11 March 2021
Accelerating and expanding HIV services in the Central African Republic

10 March 2021
Rich nations vaccinating one person every second while majority of the poorest nations are yet to give a single dose
US, UK and EU blocking proposals at WTO to help poorer countries get vaccines more quickly
One year on from the declaration of the COVID-19 pandemic, the People’s Vaccine Alliance is warning that developing countries are facing critical shortages of oxygen and medical supplies to cope with COVID-19 cases yet the majority have been unable to administer a single dose of a COVID-19 vaccine. In contrast rich nations have vaccinated their citizens at a rate of one person per second over the last month.
Many of these rich nations, including the US, UK and EU, are blocking a proposal by over 100 developing countries to be discussed at the World Trade Organisation (WTO) today, which would override the monopolies held by pharmaceutical companies and allow an urgently needed scale up in the production of safe and effective COVID-19 vaccines to ensure poorer countries get access to the doses they desperately need.
While more poor countries will see the arrival of doses in the coming days from the World Health Organisation’s COVAX facility, the amounts available mean only three per cent of people in those countries can hope to be vaccinated by mid-year, and only one fifth at best by the end of 2021.
Almost one million people worldwide have signed a call by the People’s Vaccine Alliance – a group of campaigning organisations including Oxfam, Frontline AIDS, UNAIDS, Global Justice Now and the Yunus Centre – for rich nations to stop protecting big pharma monopolies and profits over people’s lives. On 11 March protests will take place outside pharmaceutical headquarters as part of a global day of action by activists across the world…

8 March 2021
Tackling gender inequalities and gender-based violence during the COVID-19 pandemic in Asia and the Pacific

8 March 2021
Children living with HIV lagging behind adults in access to treatment


UNDP United Nations Development Programme [to 13 Mar 2021]
Latest from News Centre
COVID-19 and crisis contexts one year on: What have we learnt? How can we fast-track recovery?
Statement delivered by Haoliang Xu as part of UNDP’s Development Dialogues: Rethinking solutions to crisis in the Decade of Action series
Posted on March 11, 2021


UNESCO [to 13 Mar 2021]
Selected Latest News
No new digest content identified.


UNHCR Office of the United Nations High Commissioner for Refugees [to 13 Mar 2021]
Selected Announcements
Rwanda vaccinates refugees and asylum-seekers against COVID-19
12 Mar 2021
[See COVID above for detail]


UNICEF [to 13 Mar 2021]
Selected Press releases, Statements
Press release 03/10/2021
Across virtually every key measure of childhood, progress has gone backward, UNICEF says as pandemic declaration hits one-year mark
Spokespeople available for interview

Press release 03/10/2021
Syria conflict 10 years on: 90 per cent of children need support as violence, economic crisis and COVID-19 pandemic push families to the brink
Almost 12,000 children killed or injured in the past decade, according to verified data – an average of more than three children a day

Press release 03/07/2021
10 million additional girls at risk of child marriage due to COVID-19
With 25 million child marriages averted in the last decade, UNICEF issues warning on International Women’s Day that these gains are now under serious threat


Unitaid [to 13 Mar 2021]
Featured News
08 March 2021
Improving outcomes for women and children – Unitaid publishes its RMNCH Thematic Narrative

08 March 2021
Unitaid achieves top rating for promoting gender equality in Global Health 50/50 report


Vaccination Acceptance Research Network (VARN) [to 13 Mar 2021]
No new digest content identified.


Vaccine Confidence Project [to 13 Mar 2021]
News, Research and Reports
Coronavirus global impact
Launched April 2, 2020 and recurring every 3 days, Premise Data is utilizing its global network of Contributors to assess economic, social, and health sentiment surrounding the coronavirus (COVID-19).


Vaccine Education Center – Children’s Hospital of Philadelphia [to 13 Mar 2021]
No new digest content identified.


Wellcome Trust [to 13 Mar 2021]
No new digest content identified.


The Wistar Institute [to 13 Mar 2021]
Press Releases
Mar. 12, 2021
RNA Editing Protein ADAR1 Protects Telomeres and Supports Proliferation in Cancer Cells
Isoform preserves telomere stability by preventing accumulation of R-loops, emerging as a new cancer cell vulnerability that could be therapeutically targeted.


WFPHA: World Federation of Public Health Associations [to 13 Mar 2021]
Latest News
Now Is the Time for Effective Collaboration!
Mar 8, 2021
Now Is the Time for Effective Collaboration! The COVID-19 pandemic has exposed systemic frailties and shortcomings throughout health systems worldwide. Recently, the crisis surpassed a devastating milestone, with over 2.3 million people having died…


World Bank [to 13 Mar 2021]
Selected News, Announcements
Cabo Verde Received the First Batch of COVID-19 Vaccines
United Nations, Praia, March 12, 2021 – Cabo Verde received Friday, March 12, its first batch of the AstraZeneca-Oxford vaccine, sent through the COVAX Initiative, a partnership between the Government…
Date: March 12, 2021 Type: Press Release


World Customs Organization – WCO [to 13 Mar 2021]
Latest News – Selected Items
09 March 2021
Launch of a new WCO project on Customs control of fake vaccines and other illicit goods linked to COVID-19
The distribution of COVID-19 vaccines is of primary importance to every nation, and the transportation of vaccines across borders is becoming the world’s largest and fastest operation ever. Consequently, there is a risk that criminal syndicates may attempt to exploit the situation.

In response to this risk, and to address the threat posed by illegal products such as dangerous, sub-standard or counterfeit medicines and vaccines, the World Customs Organization (WCO) has just launched a new initiative entitled “Project on the urgent need for facilitation and coordinated Customs control of cross-border consignments linked to COVID-19”.

The aim of this project, which is funded by Japan Customs, is to stop cross-border consignments of fake vaccines and other illicit goods linked to COVID-19, while ensuring the smooth movement of the corresponding, legitimate shipments.

“In the context of the pandemic, it is crucial that Customs facilitates, to the greatest extent possible, legitimate trade in vaccines, medicines and medical supplies linked to COVID-19. However, Customs also has a determinant role to play in the fight against the illicit trade in similar sub-standard or counterfeit goods to protect societies,” said WCO Secretary General Dr. Kunio Mikuriya.

This project is part of the actions referred to in the WCO Council Resolution adopted in December 2020 on the Role of Customs in Facilitating the Cross-Border Movement of Situationally Critical Medicines and Vaccines.

Its objectives include the application of a coordinated Customs approach, in close cooperation with vaccine-producing companies and the transport industry as well as with other international organizations, to the control of international trade flows of these goods.

Also envisaged under this initiative is the use of updated versions of CEN applications to analyse new trends in illicit trade, as well as capacity building activities to raise awareness on trade in fake vaccines and other illicit goods…


World Organisation for Animal Health (OIE) [to 13 Mar 2021]
Press Releases
No new digest content identified.


WTO – World Trade Organisation [to 13 Mar 2021]
WTO News and Events
DG calls on COVID-19 vaccine manufacturers to increase production in developing countries
9 March 2021
Director-General Ngozi Okonjo-Iweala on 9 March called on COVID-19 vaccine manufacturers to do more to ramp up production in developing countries to combat the vaccine supply shortage that is excluding many lower-income nations from access. In remarks to an event hosted by the UK think tank Chatham House, she said cooperation on trade, and action at the WTO, would help accelerate vaccine scale-up.





ARM [Alliance for Regenerative Medicine] [to 13 Mar 2021]
Press Releases – Alliance for Regenerative Medicine (
Press Releases
No new digest content identified.


BIO [to 13 Mar 2021]
Press Releases
BIO responds to Congress’ Covid-19 relief package
March 10, 2021
Today, Congress passed the “American Rescue Plan” – a $1.9 trillion coronavirus relief package aimed at alleviating some of the economic and health impacts of the COVID-19 pandemic. Upon passage of the bill, Dr. Michelle McMurry-Heath, president…

Letter to President Biden Discusses Collaboration To Boost Access to COVID-19 Treatments
March 8, 2021
Dr. Michelle McMurry-Heath, president and CEO of the Biotechnology Innovation Organization (BIO), sent a letter to President Biden outlining ways the public and private sectors can best work with global partners to ensure that patients around the…


DCVMN – Developing Country Vaccine Manufacturers Network [to 13 Mar 2021]
News; Upcoming events
No new digest content identified.


ICBA – International Council of Biotechnology Associations [to 13 Mar 2021]
No new digest content identified.


IFPMA [to 13 Mar 2021]
Selected Press Releases, Statements, Publications
Meeting discusses COVID-19 vaccine manufacturing bottlenecks that must be urgently tackled for C19 vaccine output
09 March 2021
[See COVID above for detail]

ICC innovation Principles for Policymakers – Creating and nurturing innovation ecosystems
Position Paper
10 March 2021


PhRMA [to 13 Mar 2021]
Selected Press Releases, Statements
ICYMI: WSJ showcases breakthrough science of COVID-19 vaccines and implications for future medicines
March 8, 2021 Andrew Powaleny
Building on deep scientific knowledge gained from decades of experience with viruses such as MERS, SARS, influenza, HIV and Hepatitis C, biopharmaceutical companies have made unprecedented progress in advancing treatments and vaccines to help fight COVID-19. At this time, three vaccines and several treatments have received emergency use authorizations (EUAs) from the U.S. Food and Drug Administration (FDA) with one treatment receiving FDA approval. Additional candidates under investigation have also shown promise.